Robert Martin attacked in yet another letter to the editor.
What happens if nobody can afford drugs?
Saturday, August 28, 2004
In the recent letter "Drug companies aren’t much good if they go bankrupt," Robert Martin replies to my earlier letter.
Martin’s defense of the drug companies completely ignores a very real problem that many Americans have: a desperate need for drugs but no ability to pay for them. If I understand correctly, Martin is saying if you can’t pay the price, you are not entitled to the drugs. We know, however, that the price is inflated, because Canadians can buy American drugs for far less than Americans can buy American drugs.
He accuses me of having "outlined the dangerous, fallacious and criminal basis of the entitlement mentality." Who is entitled to desperately needed drugs, only the wealthy?
If Martin’s position is taken to one extreme, he is correct. If there is not sufficient incentive, the drug companies will not develop new drugs and may go bankrupt. This is bad for the drug companies and bad for the people who need the drugs.
If the situation is taken to another extreme, he is wrong. If the drug companies’ customer base cannot afford the drugs and it becomes a trade-off between food and rent or drugs, those who can’t afford the drugs die off, and the customer base shrinks. This is also not good for either the drug companies or for the people who need the drugs.
The capitalistic, free-market system is based on maximizing profit, and it turns out to be the most efficient system for delivering goods and services. However, a drug patent gives a company an exclusive right to make this drug for a number of years and to set a high price on the drug without free competition, and without concern for the effect on people’s lives.
In return for the patent protection for essential goods and services, there needs to be some form of regulation on price and delivery, which allows the monopolistic provider a reasonable profit margin and recovery of researchand-development expenses, but not excessive profits and prices that limit access to the goods and services.
Government-regulated industries can run efficiently, providing essential services at a price acceptable to the service provider. An example is Medicare.
Medicare should be allowed to negotiate drug prices and to regulate prices on patented drugs. Medicare should be acting to help the American people, not to protect the drug companies’ excessive profit margins and force the price beyond the ability of many Americans to pay.
I intend to pursue this matter by questioning my senators and representative on where they stand on drug pricing, on purchasing drugs from Canada and on the amount of campaign donations they receive from the drug industry and then spread the word. I will vote for or against these people based on the answers I receive and encourage others to do the same.
We must take back the control of the government from the drug companies by educating our friends and neighbors on what is happening and using the ultimate weapon, the vote.
In the meantime, do what any freemarket person would do: Buy your drugs from Canada.
KENNETH M. POVENMIRE
Columbus
http://www.dispatch.com/editorials-story.p...0828-A9-02.html